Fuel specification,energy consumption and CO2 emission in oil refineries

The more stringent environmental quality specifications for oil products worldwide are tending to step up energy use and, consequently, CO₂ emissions at refineries. In Brazil, for example, the stipulated reduction in the sulfur content of diesel and gasoline between 2002 and 2009 should increase the energy use of Brazil's refining industry by around 30%, with effects on its CO₂ emissions. Thus, the world refining industry must deal with trade-offs between emissions of pollutants with local impacts (due to fuel specifications) and emissions of pollutants with global impacts (due to the increased energy use at refineries to remove contaminants from oil products). Two promising technology options for refineries could ease this clash in the near-to-mid term: the reduction per se of the energy use at the refinery; and the development of treatment processes using non-hydrogen consuming techniques. For instance, in Brazilian refineries, the expanded energy use resulting from severe hydrotreatment to comply with the more stringent specifications of oil products may be almost completely offset by energy saving options and alternative desulfurization techniques, if barriers to invest in technological innovations are overcome.     

Joint international evaluation of Milking Shorthorn dairy cattle for production traits

Pedigree information and test-day records for the first 3 parities of Milking Shorthorn dairy cattle from 5 countries were analyzed. After editing, the data included 1,018,528 test-day records from 68,653 cows. A multiple-lactation random regression test-day model with Legendre polynomials of order 4 and a Bayesian method were used to estimate variance components for both single and multiple-countries. Fixed effects included herd-test-day class and regressions on DIM within age at calving-parity-season of calving. Random effects included animal genetic, permanent environmental, and residual effects. Average daily heritabilities from single country analyses ranged from 0.33 to 0.47 for milk yield and from 0.37 to 0.45 for protein yield across lactations and countries. Common sires (66) and their daughters were identified for creating a connected data set for simultaneous (co)variance component estimation of milk yield across all 5 countries. Between-country genetic correlations were low, with values from 0.08 to 0.46 and standard deviations from 0.08 to 0.12. Estimated breeding values for milk were generated for each animal using the same test-day animal model. Correlations among country estimated breeding values were higher than genetic correlations. Top 100 bull lists were generated on the scale of each country, and genetic progress was assessed. Future evaluation with increased genetic ties among countries may facilitate international comparison of Milking Shorthorns.     

The effect of surface condition and sulfur on the environmental resistance of airfoils

The environmental protection of aircraft engine high-pressure turbine blades is dependent upon the formation of a thin, slow-growing, external alumina scale. The adherence of alumina (Al₂O₃) scales to superalloys or coatings has been shown to be improved by adding an oxygen-active element (Y) or by desulfurization. Studies will be presented that show that cast surfaces are contaminated with sulfur and are more susceptible to high-velocity oxidation than machined surfaces regardless of an oxygen-active-element addition. In addition, the positive effect of oxygen-active elements and desulfurization on the performance of a single-crystal and directionally solidified Ni-base super-alloy in a 1149°C cyclic oxidation test and a 927°C/5 ppm sea-salt Type-I hot-corrosion test will be discussed.     

Coagulation factor Xa induces endothelium-dependent relaxations in rat aorta

The relaxing effect of coagulation factor Xa on phenylephrine-contracted rat aortic rings was compared with the effect of thrombin and trypsin. All three proteases induced a dose-dependent relaxation in the presence of an intact endothelium. EC50 values were 3 +/- 1, 24 +/- 9, and 16 +/- 1 nmol/L for thrombin, trypsin, and factor Xa, respectively. Whereas thrombin induced rapid relaxations followed by partial recontraction, trypsin and factor Xa induced slower sustained effects. Factor Xa-induced relaxations were not affected by hirudin at high concentrations (1 mumol/L) but were abolished by DX9065A, a specific inhibitor of the catalytic activity of factor Xa. Furthermore, no relaxations to factor Xa could be elicited in the presence of the NO synthase inhibitor N omega-nitro-L-arginine methyl ester (100 mumol/L), whereas relaxations were not altered in the presence of the inactive enantiomer N omega-nitro-D-arginine methyl ester (100 mumol/L). Addition of factor Xa together with thrombin induced relaxations that were larger than those induced by thrombin alone, whereas factor Xa had no additional effects on trypsin-induced relaxations. Further-more, factor Xa relaxed thrombin-desensitized aortic rings but was ineffective in trypsin-desensitized tissues. These data suggest that factor Xa acts on a cleavable endothelial receptor that induces NO release, resulting in the relaxation of precontracted rat aortic rings. Factor Xa does not act through endothelial thrombin receptors but may activate another cleavable trypsin-sensitive receptor.     

Heart and autonomic nervous system in connective tissue disorders

Heart rate variability (HRV) is a suitable diagnostic tool in identifying patients with autonomic nervous system (ANS) disorders even in pre-clinical stage. We have enrolled in this study all patients with large variety of connective tissue disorders, given the possibility of an involvement of ANS in these diseases. The study population consisted in eighty-five patients (68 females and 17 males), 35 of whom affected by systemic lupus erythematosus, 16 by rheumatoid arthritis, 14 by Sj?gren syndrome, 12 by progressive systemic sclerosis, 3 by Beh?et syndrome and 5 by antiphospholipid antibodies syndrome. The mean age ranged between 33.7 of patients with lupus erythematosus and 51.8 of those with Sj?gren syndrome. As control, we enrolled healthy subjects of different age, divided into two groups, to rule out the aging as potential source of considered parameters alteration. The autonomic function has been evaluated by 24 hours ambulatory monitoring, using a Zymed 1210 Scanner with Zymed 3.74-PC 1990 software. We have considered: in the time domain, the standard deviation of the RR intervals average (SDNN) and the percentage of RR adjacent intervals differing each other more than 50 msec (pNN50); in the frequency domain, the low (LF) and high (HF) frequencies, the LF/HF ratio, and the total power (RT). The HRV parameters resulted abnormal in every type of the connective tissue diseases considered: particularly SDNN, pNN50, LF, HF and RT (p < or = 0.01). In conclusion: the results of our study suggest that autonomic neuropathy may be present in any kind of connective tissue disorders even in preclinical stage.     

Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization

Avermectins are a class of macrocyclic lactones that is widely used in crop protection and to treat helminth infections in man and animals. Two complementary DNAs (GluClalpha and GluClbeta) encoding chloride channels that are gated by avermectin and glutamate, respectively, were isolated from Caenorhabditis elegans. To study the role of these subunits in conferring avermectin sensitivity we isolated a mutant C. elegans strain with a Tc1 transposable element insertion that functionally inactivated the GluClalpha gene (GluClalpha::Tc1). GluClalpha::Tc1 animals exhibit a normal phenotype including typical avermectin sensitivity. Xenopus oocytes expressing GluClalpha::Tc1 strain mRNA elicited reduced amplitude avermectin and glutamate-dependent chloride currents. Avermectin binding assays in GluClalpha::Tc1 strain membranes showed the presence of high affinity binding sites, with a reduced Bmax. These experiments suggest that GluClalpha is a target for avermectin and that additional glutamate-gated and avermectin-sensitive chloride channel subunits exist in C. elegans. We isolated a cDNA (GluClalpha2) encoding a chloride channel that shares 75% amino acid identity with GluClalpha. This subunit forms homomeric channels that are gated irreversibly by avermectin and reversibly by glutamate. GluClalpha2 coassembles with GluClbeta to form heteromeric channels that are gated by both ligands. The presence of subunits related to GluClalpha may explain the low level and rarity of target site involvement in resistance to the avermectin class of compounds.     

Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins

The human immunodeficiency virus type 1 (HIV-1) nucleocapsid p7 protein contains two retrovirus-type zinc finger domains that are required for multiple phases of viral replication. Chelating residues (three Cys residues and one His residue) of the domains are absolutely conserved among all strains of HIV-1 and other retroviruses, and mutations in these residues in noninfectious virions. These properties establish the zinc finger domains as logical targets for antiviral chemotherapy. Selected dithiobis benzamide (R-SS-R) compounds were previously found to inhibit HIV-1 replication by mediating an electrophilic attack on the zinc fingers. Unfortunately, reaction of these disulfide-based benzamides with reducing agents yields two monomeric structures (two R-SH structures) that can dissociated and no longer react with the zinc fingers, suggesting that in vivo reduction would inactivate the compounds. Through an extensive drug discovery program of the National Cancer Institute, a nondissociable tethered dithiane compound (1,2-dithiane-4,5-diol, 1,1-dioxide, cis; NSC 624151) has been identified. This compound specifically attacks the retroviral zinc fingers, but not other antiviral targets. The lead compound demonstrated broad antiretroviral activity, ranging from field isolates and drug-resistant strains of HIV-1 to HIV-2 and simian immunodeficiency virus. The compound directly inactivated HIV-1 virions and blocked production of infectious virus from cells harboring integrated proviral DNA. NSC 624151 provides a scaffold from which medicinal chemists can develop novel compounds for the therapeutic treatment of HIV infection.